Abid A, Sabolovic N, Magdalou J
Centre du Medicament, URA CNRS 597, Nancy, France.
Cell Biol Toxicol. 1996 Apr;12(2):115-23. doi: 10.1007/BF00143361.
Two human hepatoma cell lines, KYN-2 and Mz-Hep-1 were characterized in terms of glucuronidation capacity and inducibility of cytochrome P4501A1/1A2 and several UDP-glucuronosyltransferases (UGTs). Cytochrome P4501A1/1A2 activity was measured using 7-ethoxyresorufin and that of UGTs with 16 different substrates. The effects of dimethyl sulfoxide (DMSO), 3-naphthoflavone, alpha-naphthoflavone, and rifampicin on these drug-metabolizing enzyme activities were studied. DMSO treatment increased in a dose-dependent manner the ethoxyresorufin O-deethylase (EROD) activity in KYN-2 cells, while an opposite effect was observed in Mz-Hep-1 cells. In KYN-2 cells, EROD was more responsive toward beta-naphthoflavone treatment in combination with DMSO. This activity was enhanced in Mz-Hep-1 cells more than 83 times by beta-naphthoflavone. The enhancement of EROD activity by DMSO and beta-naphthoflavone treatments of KYN-2 cells was abolished by alpha-naphthoflavone treatment. In Mz-Hep-1, only the inducing effect of beta-naphthoflavone was abolished by alpha-naphthoflavone treatment. Rifampicin treatment of KYN-2 cells reversed both the DMSO and beta-naphthoflavone effects on the EROD activity. Glucuronidation of steroids, bile acids, fatty acids and drugs was effective in KYN-2 and Mz-Hep-1 cells. Both 1-naphthol glucuronidation and the level of UGT1*6 protein detected by immunoblot and supporting this activity were lowered by DMSO treatment and increased by beta-naphthoflavone treatment in KYN-2 cells. In Mz-Hep-1 cells, DMSO and beta-naphthoflavone had no effect on 1-naphthol glucuronidation activity. DMSO, beta-naphthoflavone and rifampicin also affected the glucuronidation of various substrates supported by different UGT isoforms. These results indicate that KYN-2 and Mz-Hep-1 cells can be used as new in vitro models for the studies of drug metabolism and the regulation of the corresponding enzymes.
对两种人肝癌细胞系KYN - 2和Mz - Hep - 1在葡萄糖醛酸化能力以及细胞色素P4501A1/1A2和几种尿苷二磷酸葡萄糖醛酸基转移酶(UGTs)的诱导性方面进行了表征。使用7 - 乙氧基异吩嗪酮测定细胞色素P4501A1/1A2的活性,并使用16种不同底物测定UGTs的活性。研究了二甲基亚砜(DMSO)、3 - 萘黄酮、α - 萘黄酮和利福平对这些药物代谢酶活性的影响。DMSO处理以剂量依赖性方式增加了KYN - 2细胞中乙氧基异吩嗪酮O - 脱乙基酶(EROD)的活性,而在Mz - Hep - 1细胞中观察到相反的效果。在KYN - 2细胞中,EROD对与DMSO联合的β - 萘黄酮处理反应更敏感。β - 萘黄酮使Mz - Hep - 1细胞中的这种活性增强了83倍以上。α - 萘黄酮处理消除了DMSO和β - 萘黄酮处理对KYN - 2细胞EROD活性的增强作用。在Mz - Hep - 1中,α - 萘黄酮处理仅消除了β - 萘黄酮的诱导作用。利福平处理KYN - 2细胞逆转了DMSO和β - 萘黄酮对EROD活性的影响。类固醇、胆汁酸、脂肪酸和药物的葡萄糖醛酸化在KYN - 2和Mz - Hep - 1细胞中有效。在KYN - 2细胞中,DMSO处理降低了1 - 萘酚葡萄糖醛酸化以及通过免疫印迹检测到的支持该活性的UGT1*6蛋白水平,而β - 萘黄酮处理则使其增加。在Mz - Hep - 1细胞中,DMSO和β - 萘黄酮对1 - 萘酚葡萄糖醛酸化活性没有影响。DMSO、β - 萘黄酮和利福平还影响了不同UGT同工型支持的各种底物的葡萄糖醛酸化。这些结果表明,KYN - 2和Mz - Hep - 1细胞可作为研究药物代谢和相应酶调节的新体外模型。